Please login to the form below

Not currently logged in
Email:
Password:

Former AstraZeneca VP joins Walgreens

Mark Lelinski leaves pharma for pharmacy

Mark Lelinksi WalgreensThe US' leading pharmacy group Walgreens has tapped the pharma industry to lead its efforts in market access.

Mark Lelinski (pictured) will leave his role as VP, Americas region marketing and sales, at pharma company AstraZeneca (AZ) to join the drug retailer, which holds a 45 per cent stake in fellow pharmacy group Alliance Boots.

As Walgreens' corporate VP, market access, he will be responsible for the company's contracting and pricing strategies, as well as integration efforts across the pharmacy, health and wellness division and managing market strategies.

Lelinksi spent a total of nine years at AZ in several marketing and strategy roles, during which time he was responsible for implementing new commercial capabilities across the US and Canada and building new capabilities in Latin America to improve market access.

Prior to joining AstraZeneca, Lelinski was a partner at Accenture, where he headed the pharmaceutical marketing and sales effectiveness practice.

“His experience in managed market roles both in the US and internationally is the right fit for where Walgreens is headed,” said Kermit Crawford, Walgreens president of pharmacy, health and wellness.

“As a strategic partner of choice in the healthcare industry, we believe Mark's relationship-driven approach will help us strengthen our partnerships and create more value from the emerging models and markets that will be key to our growth moving forward.”

18th July 2013

From: Sales, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics